Free Trial

Put High-Yield Paychex, Inc. On Your Watchlist 

Key Points

  • Paychex outperformed expectations, but the response was muted due to a need for more. 
  • The dividend is safe and yields 2.7%. 
  • Guidance is positive but may not spark a rally until later in the year. 
  • Five stocks we like better than Paychex.

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Paychex Right Now?

Before you consider Paychex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Paychex wasn't on the list.

While Paychex currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Thomas Hughes
About The Author

Thomas Hughes

Contributing Author

Technical and Fundamental Analysis

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Automatic Data Processing (ADP)
4.3899 of 5 stars
$311.21-0.7%1.98%32.45Hold$293.55
Cintas (CTAS)
4.6477 of 5 stars
$204.31-0.7%0.76%49.26Hold$199.79
Paychex (PAYX)
3.6425 of 5 stars
$149.26-1.2%2.63%31.42Reduce$132.23
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

HIMS Stock Up 120%! More Growth Ahead?

HIMS Stock Up 120%! More Growth Ahead?

Hims & Hers (NYSE: HIMS) has skyrocketed 120% in just a month! Is it the next big disruptor in healthcare, or is it overpriced?

Recent Videos

NVIDIA Revenue SOARS 78%, But Volatility Won’t STOP!
7 High-Growth Stocks Under $10
These Are the 3 Stocks Most Likely to SPLIT in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines